Q0162 Ondansetron oral
Also known as: Zofran, ondansetron, 5-HT3 antagonist
Ondansetron oral formulation, a selective serotonin 5-HT3 receptor antagonist antiemetic used for nausea and vomiting prevention.
In Plain Language
anti-nausea pill; anti-vomiting medication
Clinical Context
Widely used for chemotherapy-induced nausea/vomiting, postoperative nausea, and radiation-induced emesis. Often dosed 4-8 mg orally for prevention or treatment.
RVU Information
CPT Q0162 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q0162?
CPT Q0162 (Ondansetron oral) is a Q Codes code. Ondansetron oral formulation, a selective serotonin 5-HT3 receptor antagonist antiemetic used for nausea and vomiting prevention.
Is Q0162 covered by insurance?
Q0162 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Widely used for chemotherapy-induced nausea/vomiting, postoperative nausea, and radiation-induced emesis. Often dosed 4-8 mg orally for prevention or treatment.
When is CPT Q0162 used?
Widely used for chemotherapy-induced nausea/vomiting, postoperative nausea, and radiation-induced emesis. Often dosed 4-8 mg orally for prevention or treatment.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.